Richman Michael has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 38190 shares of NextCure, Inc. ($NXTC) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | NextCure, Inc. | $NXTC | Richman Michael | President & CEO | A | Employee Stock Option (Right to Buy) | 38190 | $0.00 | 38,190.0000 | 2,842,448 | 9999.99% | 1.34% |
| Jan. 31, 2025 | NextCure, Inc. | $NXTC | Richman Michael | President & CEO | A | Employee Stock Option (Right to Buy) | 305500 | $0.00 | 305,500.0000 | 2,330,386 | 9999.99% | 13.11% |
| March 29, 2024 | NextCure, Inc. | $NXTC | Richman Michael | President & CEO | A | Employee Stock Option (Right to Buy) | 244400 | $0.00 | 244,400.0000 | 27,836,584 | 9999.99% | 0.88% |
| Jan. 31, 2024 | NextCure, Inc. | $NXTC | Richman Michael | President & CEO | A | Employee Stock Option (Right to Buy) | 305500 | $0.00 | 305,500.0000 | 27,836,584 | 9999.99% | 1.10% |